First case of Abiotophia defectiva infectious endocarditis treated with a combination of amoxicillin and daptomycin

J Chemother. 2020 Oct;32(6):323-325. doi: 10.1080/1120009X.2020.1734163. Epub 2020 Mar 12.

Abstract

Abiotophia defectiva (A. defectiva) infectious endocarditis (IE) is a serious disease that usually requires lengthy treatment with a combination of amoxicillin and gentamicin. Since severe nephrotoxicity can be associated with prolonged administration of gentamicin, the alternative use of daptomycin in combination with amoxicillin can be considered. We present the case of a 51-year-old man that presented an A. defectiva endocarditis on an aortic bicuspidy. Diagnosis of cirrhosis was made simultaneously, and therefore gentamicin was counter-indicated. A combination of amoxicillin 12 g per day and daptomycin 700 mg (10 mg/kg) was administrated, with resolution of clinical, biological and echographic abnormalities, and no relapse after 1 year. In our experience, amoxicillin with daptomycin could be an alternative in case of A. defectiva IE with counter-indication to aminoglycosides.

Keywords: Abiotrophia defectiva; aminoglycoside; daptomycin; endocarditis; infection.

Publication types

  • Case Reports

MeSH terms

  • Abiotrophia / drug effects
  • Abiotrophia / isolation & purification*
  • Amoxicillin / administration & dosage*
  • Anti-Bacterial Agents / administration & dosage*
  • Daptomycin / administration & dosage*
  • Drug Therapy, Combination
  • Endocarditis, Bacterial / drug therapy*
  • Endocarditis, Bacterial / microbiology
  • Gram-Positive Bacterial Infections / drug therapy*
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Male
  • Middle Aged

Substances

  • Anti-Bacterial Agents
  • Amoxicillin
  • Daptomycin

Supplementary concepts

  • Abiotrophia defectiva